114 related articles for article (PubMed ID: 8097708)
1. Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.
Thummel KE; Kharasch ED; Podoll T; Kunze K
Drug Metab Dispos; 1993; 21(2):350-7. PubMed ID: 8097708
[TBL] [Abstract][Full Text] [Related]
2. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
Kharasch ED; Thummel KE
Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
[TBL] [Abstract][Full Text] [Related]
3. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of 1,1,1,2-tetrafluoroethane in rat liver microsomes is catalyzed primarily by cytochrome P-450IIE1.
Olson MJ; Kim SG; Reidy CA; Johnson JT; Novak RF
Drug Metab Dispos; 1991; 19(2):298-303. PubMed ID: 1676626
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
Garton KJ; Yuen P; Meinwald J; Thummel KE; Kharasch ED
Drug Metab Dispos; 1995 Dec; 23(12):1426-30. PubMed ID: 8689955
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.
Chang TK; Weber GF; Crespi CL; Waxman DJ
Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617
[TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
[TBL] [Abstract][Full Text] [Related]
8. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
10. Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane.
Surbrook SE; Olson MJ
Drug Metab Dispos; 1992; 20(4):518-24. PubMed ID: 1356728
[TBL] [Abstract][Full Text] [Related]
11. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED
J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off.
Jayyosi Z; Knoble D; Muc M; Erick J; Thomas PE; Kelley M
J Pharmacol Exp Ther; 1995 Jun; 273(3):1156-61. PubMed ID: 7791086
[TBL] [Abstract][Full Text] [Related]
14. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F
Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans.
Dupont I; Berthou F; Bodenez P; Bardou L; Guirriec C; Stephan N; Dreano Y; Lucas D
Drug Metab Dispos; 1999 Mar; 27(3):322-6. PubMed ID: 10064561
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
Labroo RB; Paine MF; Thummel KE; Kharasch ED
Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
[TBL] [Abstract][Full Text] [Related]
17. Role of human hepatic cytochrome P-450s in territrem A metabolism.
Peng FC; Tseng HY; Tsai JC; Lin C; Doehmer J
J Toxicol Environ Health A; 2003 Jul; 66(13):1237-48. PubMed ID: 12851121
[TBL] [Abstract][Full Text] [Related]
18. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
Koyama E; Chiba K; Tani M; Ishizaki T
J Pharmacol Exp Ther; 1996 Jul; 278(1):21-30. PubMed ID: 8764331
[TBL] [Abstract][Full Text] [Related]
19. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
Powell PK; Wolf I; Lasker JM
Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
[TBL] [Abstract][Full Text] [Related]
20. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR
Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
